Portfolio

LSP HEF 2

Investments range between EUR 10 million and EUR 30 million

LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US.

LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands

Company Registration Number: 34296447

LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.

Fast facts

  • Status
    Aktiv
  • Launch
    2018
  • Storlek
    EUR 280 miljoner

Investment advisory committee

  • Chairperson
    Andre Olijslager
  • Perfuze
  • Nobi
  • DOTS Technology
  • Atlantic Therapeutics
  • Neurent Medical
  • Aelin Therapeutics
  • One Projects
  • iStar Medical
  • Lumeon
  • Endotronix
  • Vicentra

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180